Over the years, we have undertaken several commercial trials. We currently have approximately 10 commercial trials of symptomatic (e.g. for spasticity) or disease modifying treatments for MS, funded by pharmaceutical companies. For details of our ongoing commercial trials, please see: https://www.nottingham.ac.uk/research/groups/clinicalneurology/trials/index.aspx

Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.